Related Experiment Video
Updated: May 3, 2026

05:30
Controlled Cortical Impact Model for Traumatic Brain Injury
Published on: August 5, 2014
28.8K
Risk Factors for Heterotopic Ossification in Traumatic Brain Injury: An Analysis of the Korean National Health
Seo Yeon Yoon1, Hyunsun Lim2, Jun Min Cha1
1Department and Research Institute of Rehabilitation Medicine, Yonsei University College of Medicine, Seoul, Korea.
Yonsei Medical Journal
|August 28, 2025
Summary
Heterotopic ossification (HO) risk factors in traumatic brain injury (TBI) patients include female sex, obesity, and comorbidities. Medications affecting bone metabolism and disability also increase HO risk following TBI.
Area of Science:
- Neuroscience
- Orthopedics
- Public Health
Background:
- Traumatic brain injury (TBI) can lead to heterotopic ossification (HO), a condition causing abnormal bone formation.
- Understanding HO risk factors in TBI patients is crucial for developing preventative strategies and improving patient outcomes.
Purpose of the Study:
- To investigate demographic, medical history, medication, and injury-related risk factors for HO in patients with TBI.
- To identify specific patient characteristics and clinical factors associated with increased HO incidence post-TBI.
Main Methods:
- Retrospective analysis of the Korean National Health Insurance Service (KNHIS) database.
- Inclusion of adult patients diagnosed with TBI (ICD-10 code S06) between 2004 and 2018.
- Analysis of factors including demographics, comorbidities, medications, and accompanying injuries.
Main Results:
- HO developed in 0.30% (1909/637315) of TBI patients.
- Risk factors included female sex, middle age (50s), preobesity/obesity, rheumatic diseases, comorbidities, and tracheostomy.
- Protective factors included smoking, anticonvulsants, antithrombotics, steroids, and NSAIDs.
Conclusions:
- Middle age, female sex, obesity, comorbidities, and disability increase HO risk in TBI patients.
- Certain medications (antiseptics) are associated with increased risk, while others (anticonvulsants, steroids, NSAIDs) are associated with decreased risk.
- Injury severity and systemic inflammation are implicated in HO development post-TBI.

